Reviewed
Verified by SAC team
+20
XP on completion
Best Therapeutic Dose
Thorne

Thorne 5-MTHF 1 mg (Methylfolate) Review

Thorne is a gold-standard clinician brand, and this is its therapeutic-dose methylfolate: 1 mg (1,000 mcg) of L-5-MTHF, third-party tested. For someone with elevated homocysteine, a documented MTHFR variant, or a clinician's instruction to take a higher active-folate dose, it is a well-made, trustworthy choice. But read the dose honestly — 1 mg is well above the 400–800 mcg prenatal target, and for the general population that extra is neither needed nor proven to help. It ranks in the lower half because it pairs a premium price with a dose most women simply do not require, in a form without NTD-prevention evidence.

Check on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

Read the complete Folate guide →
▸ THE SCORE

How we built the SAC Product Score™6.6/10

NTD-Prevention Evidence30%5/10

Methylfolate lacks NTD-prevention trials, and a therapeutic dose does not change that — no evidence 1 mg prevents more defects than 400 mcg folic acid.

Form & Bioavailability20%9/10

Bioidentical L-5-MTHF, conversion-free, from a brand with rigorous quality control.

Dose Appropriateness20%6/10

1 mg is above the 400–800 mcg prenatal window — appropriate for therapeutic use but excessive for routine prevention.

Third-Party Testing20%8/10

Thorne is known for rigorous third-party testing and athletic-grade quality control.

Value10%5/10

About $22 for 60 capsules — a premium price for a dose most buyers don't need.

▸ SPECS

The product at a glance

Form
L-5-MTHF capsule
Dose
1 mg (1,000 mcg) L-5-MTHF
Count
60 capsules
Testing / Certification
Third-party tested, Gluten Free, Dairy/Soy Free
Cost per dose
~$0.37 per capsule
▸ TRUTH CHECK

Marketing claims vs. reality

Partial

1 mg methylfolate is better for MTHFR carriers

Active folate bypasses conversion and higher doses can lower homocysteine, but there is no evidence a 1 mg dose improves pregnancy outcomes over standard 400–800 mcg for typical carriers (PMID 19298256, PMID 23482308).

Not verified

Therapeutic-dose folate prevents NTDs better

No trial shows 1 mg methylfolate prevents more neural-tube defects than the standard folic acid dose; folic acid holds the prevention evidence.

▸ THE DEEP DIVE

What our test actually found

01Great brand, wrong tool for routine prevention

Thorne's quality is real, but 1 mg of active folate is a therapeutic dose aimed at homocysteine or methylation issues — not the profile a healthy woman needs for basic NTD prevention.

02More is not better here

Above the 400–800 mcg target there is no added NTD-prevention benefit, and high active-folate intakes are still an area of ongoing study — so the extra milligram is cost without a proven upside for most.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Top-tier clinician brand with rigorous third-party testing
  • Bioidentical L-5-MTHF, no conversion required
  • Appropriate for elevated homocysteine or clinician-directed use
  • Free of dairy, soy and gluten
  • Reliable potency and purity
Cons
  • 1 mg dose exceeds the 400–800 mcg prenatal target for most women
  • Premium price for a dose and form most buyers don't need
▸ THE BOTTOM LINE

For a therapeutic need, not the shelf default

Buy this if a clinician has directed you to a higher active-folate dose, or you are managing elevated homocysteine. It is superbly made. But for routine preconception folate it is overkill in a form without NTD-prevention data, which is why it lands mid-pack despite the brand's excellent reputation.

Check Thorne on Amazon
▸ ALTERNATIVES

If this doesn’t fit — try these

▸ RESEARCH

Sources & further reading

  1. Prinz-Langenohl R, Brämswig S, Tobolski O, et al. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the 677C→T MTHFR polymorphism. Br J Pharmacol. 2009;158(8):2014-21.Prinz-Langenohl R, Brämswig S, Tobolski O, et al. · 2009 · British Journal of Pharmacology · PMID 19917061

    [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the 677C→T MTHFR polymorphism

    5-MTHF raised plasma folate as effectively as folic acid, including in 677TT women, at standard doses.

  2. Obeid R, Holzgreve W, Pietrzik K. Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects? J Perinat Med. 2013;41(5):469-83.Obeid R, Holzgreve W, Pietrzik K · 2013 · Journal of Perinatal Medicine · PMID 23482308

    Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects?

    Folic acid retains NTD-prevention trial evidence; methylfolate remains an unproven alternative.